MetaCap

Mirum Pharmaceuticals Cash Flow Statement

NASDAQ: MIRMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

86.01+4.66 (+5.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Pre-market: 92.00 +6.96%

Mirum Pharmaceuticals free cash flow

In fiscal 2025, Mirum Pharmaceuticals generated $55.8 million of operating cash flow and spent $954,000 on capital expenditures. That left free cash flow of $54.9 million, a free-cash-flow margin of 10.5% of revenue. Free cash flow was up 488.0% from the prior year's $9.3 million.

Summary generated from market data by MetaCap's automated system. Methodology

Mirum Pharmaceuticals cash flow statement (annual)

Mirum Pharmaceuticals annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31
Net Income-23.36M-87.94M-163.41M-135.66M-83.99M-103.27M-52.55M
Net Income growth (YoY)———————
Depreciation & Amortization24.24M23.63M10.83M3.24M595.00K305.00K139.00K
Stock-Based Compensation71.42M48.44M35.02M27.01M23.09M12.55M6.07M
Change in Working Capital-62.17M-16.09M-45.46M-24.30M-1.01M954.00K-160.00K
Operating Cash Flow55.83M10.32M-70.94M-120.14M-132.76M-89.08M-39.36M
Capital Expenditures-954.00K-993.00K-109.00K-278.00K-24.00K-225.00K-281.00K
Investing Cash Flow-23.95M-90.13M-107.20M7.70M48.55M37.87M-127.78M
Financing Cash Flow40.14M17.70M336.60M109.09M73.47M181.29M127.18M
Net Change in Cash75.24M-63.40M158.32M-3.34M-10.75M130.12M-39.99M
Free Cash Flow54.87M9.33M-71.05M-120.41M-132.78M-89.30M-39.64M

This table shows 7 annual periods of Mirum Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MIRM's reporting calendar. What is a cash flow statement?

More financial data